Transverse muscle block effect in analgesia after cesarean sectio

Not Applicable

• Conditions: acute pain after cesarean section.; Acute pain

• Registration Number: IRCT2016120431225N1
• Lead Sponsor: Vice Chancellor for research of Iran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 76

Inclusion Criteria

18-50 year old females who are candidate for spinal anesthesia for elective and emergency cesarean section due to fetal distress; patients with ASA 1 & 2. Exclusion criteria: patients with ASA>3 & 4; contraindication for the use of spinal anesthesia; Emergent conditions due to organic problems such as eclampsia, preeclampsia, placenta previa and ...; history of allergy to bupivacaine; receiving an analgesic; BMI> 40; pre-pregnancy weight less than 50 kg; patients with an underlying disease or history of renal or liver disease or coagulopathy; prediction of spinal anesthesia unsuccessfulness (including inadequate anesthetic level); patients who have received sedation drugs fentanyl 100 macrograms and midazolam 2 miligrams during the procedure.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Satisfaction of Analgesia. Timepoint: Immediately after the caesarean section and at 2, 4, 6, 12, 24 and 36 hours after intervention. Method of measurement: Questionnaire.

Secondary Outcome Measures

Name	Time	Method
Time of first opioid analgesic injection. Timepoint: The first time analgeic request by the patient. Method of measurement: Questionnaire.;Pain relief score at rest. Timepoint: 2, 4, 6, 12, 24, 36 hours after intervention. Method of measurement: Pain Score Questionnaire (zero to ten).;Patient satisfaction score. Timepoint: 36 hours after intervention. Method of measurement: Questionnaire.;Nausea and vomiting complaint. Timepoint: 2, 4, 6, 12, 24, 36 hours after intervention. Method of measurement: Questionnaire.;Amount of opioid consumption (mg). Timepoint: 36 hours after intervention. Method of measurement: Questionnaire.;Pain relief score when coughing. Timepoint: 2, 4, 6, 12, 24, 36 hours after intervention. Method of measurement: Pain Score Questionnaire (zero to ten).